|
|||||||||||
|
|
|||||||||||
| UDK 616.2-022.7-053.3 | ISSN 0350-2899, 30(2005) 1 p. 33-36 | ||||||||||
| Review RSV infection at infants and toddlers by specially intention
|
|||||||||||
|
|
|||||||||||
| Summary: The objective of this article
is to present the importance of RSV (Respiratory syncytial virus)
infection and new approaches in treatment and prophylaxis. RSV is the most
common cause of infections in neonates and suckling babies. Groups with
high risk: preterm babies, neonates with immunodeficiency, heart failure,
underweight and chronic pulmonal disease (ex. Bronchopulmonary dysplasia
(BPD), respiratory distress syndrome (RDS) etc.) need prevention. The best
prophylaxis is vaccination, but it is still being developed and
researched. RSV-IGIV passive prophylaxis (specific hyperimmune RSV immune
globulin) and Palivizumab monoclonal antibody for intramuscular use are
very useful and beneficial. They reduce the number of hospitalization
days, i.e. duration of illness, severity of reinfection, mortality and
disease development. The best antivirotic today is Ribavirin which is
inhaled for three or seven days, thus significantly improving clinical
symptoms and reducing disease duration and complications as well. Key words: RSV infection, prophylaxis, RSV-IGIV, Palivizumab, therapy, Ribavirin. Note: full text in Serbian Napomena: kompletan tekst rada na srpskom jeziku |
|||||||||||
|
Corresponding Address: Adnan Bajraktarević Husrefa Redžića 13/7 Bosna i Hercegovina, 71000 Sarajevo mob:0038761-199526, fax: 0038733-555391 e-mail: bajrakm@bih.net.ba |
|||||||||||
|
Paper received: 29.12.2004. Paper accepted: 22.02.2005. Published online: 30.04.2005. |
|||||||||||
|
|
|||||||||||
| Infotrend Crea(c)tive Design | Revised: 20 May 2009 | ||||||||||
